Market Research Blog – Page 885 – New Product Development

Hospital Stretchers Market Projected to Grow Significantly Expected Increase of USD 4.8 Billion by 2032 at a 5.7% of CAGR

The newly-released market analysis report by Future Market Insights indicates that global sales of the Hospital Stretchers market were valued at approximately USD 2.6 billion in 2021. The market is expected to witness substantial growth, with a projected CAGR of 5.7% from 2022 to 2032, surpassing historical growth rates.

Key Drivers of Market Growth

Several factors are contributing to the anticipated growth of the hospital stretchers market:

Increase in Chronic Diseases: The rising prevalence of chronic diseases is leading to an increased demand for healthcare services, thus driving the need for hospital stretchers in medical facilities.
Growing Geriatric Population: With an aging population requiring more medical attention, the demand for hospital stretchers is expected to surge, as elderly patients often need assistance during transportation and treatment.
Rising Hospitalization Rates: An increase in hospitalization rates due to various health concerns necessitates the use of advanced hospital stretchers, further fueling market growth.

Future Opportunities and Market Potential

Significant Dollar Opportunity: The hospital stretchers market is projected to witness an absolute dollar opportunity of USD 2.1 billion overall growth by 2032. This potential presents a lucrative avenue for market players to innovate and expand their product offerings.
Innovation in Design and Functionality: As healthcare facilities seek to improve patient care and operational efficiency, there is a growing demand for innovative stretcher designs that enhance safety, comfort, and mobility for patients and healthcare providers alike.

The Hospital Stretchers market is poised for impressive growth, driven by increasing healthcare needs, demographic shifts, and advancements in stretcher technology.

The absolute dollar opportunity for the Hospital Stretchers market will be US$ 2.1 Billion due to the rise in chronic diseases, a growing geriatric population, and rising hospitalization, all of which are major driving factors for the market’s expansion.

The prevalence, the sedentary lifestyles, and the prevalence of alcohol and smoking consumption are all linked to the probability of people suffering from chronic diseases. One of the chief causes of death globally is cardiovascular disease. According to the WHO, CVDs take the lives of approximately 17.9 million people every year. According to the Centers for Disease Control and Prevention, 0.8 million Americans have a heart attack per year, and approximately 0.6 million die because of this.

According to Future Market Insights’ recently published Hospital Stretchers market analysis report, the market for these products had global sales of US$ 2.6 billion in 2021. The anticipated market growth from 2022 to 2032 is anticipated to be 5.7%, which is much greater than the increase in the past. Due to the rise in chronic diseases, an aging population, and an increase in hospitalization, which are all key contributors to the industry’s growth, the total dollar opportunity for the Hospital Stretchers market will increase by US$ 2.1 billion.

The rising incidence of cancer is leading to the demand for stretchers in hospital settings. The International Agency for Research on Cancer (IARC) projects the growth of the cancer burden will reach 19.3 million cases by 2020, with 10 million deaths. Consequently, the demand for chronic diseases is among the key factors driving growth.

More fatalities and traffic accidents have motivated increased funding for emergency medical services. The WHO estimates that each year, close to 1.35 million traffic-related deaths occur worldwide (2021). By age group, fatalities occur most commonly among people under 29 and are particularly common in low- and middle-income countries.

Competitive Landscape

Product commercialization and partnership tactics are expected to be profitable for the hospital stretchers market in the forthcoming years. Market players are concentrating on various business strategies such as mergers and acquisitions, partnerships, and new product launches to strengthen their market position

The key vendors in the global Hospital Stretchers market are Hill-Rom Holdings, Stryker, Mac Medical, TransMotion Medical Inc., Fu Shun Hsing Technology, Narang Medical Limited, ROYAX, and Advanced Instrumentations.

The recent developments in hospital stretcher markets are:

In October 2020, Stryker released the ProCuity Wireless Bed, which is intended to help hospitals reduce costs, reduce the number of patients’ falls, and improve nurses’ workflow.
In September 2021, an Indian teen invented a stretcher with shock absorbers. Unlike its conventional counterparts, this stretcher is designed in such a way that the patient’s gravity point is managed using the patient’s own weight. During movement on ramps, slopes, or uneven surfaces, this is balanced on the central wheels.
In December 2021, the Neonatal Stretcher System from Technimount won the EMS World Innovation Award 2021. The Neonatal Stretcher System which consists of a support stretcher structure and adapted mounts that allow the attachment of multiple medical devices, provides safety and autonomy to neonatal transport teams.

A Full Report Overview

Market Segments Covered in Hospital Stretchers Industry Analysis

By Product Type:

Adjustable Height
Fixed Height
Bariatric
Radiographic

By Technology:

Motorized
Non-Motorized

By Application:

Ambulatory/Transport
Day-care/Inpatient
Surgery
Emergency/Trauma

By Region:

North America
Latin America
Europe
APAC
MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Complementary and Alternative Medicine for Anti-Aging & Longevity Market Set for Remarkable Growth: Projected to Reach USD 347.7 Billion by 2032

The global market for Complementary and Alternative Medicine (CAM) for anti-aging and longevity was valued at approximately USD 44.6 billion in 2021. This market is projected to experience substantial growth, with an anticipated CAGR of 24.4% from 2022 to 2032.

Key Drivers of Market Growth

Several factors are fueling the growth of the CAM market for anti-aging and longevity:

Increasing Aging Population: The rising global aging population is a significant driver of demand for alternative therapies focused on anti-aging and longevity. As more individuals seek ways to maintain vitality and enhance their quality of life, the appeal of CAM treatments is growing.
Prevalence of Age-Related Diseases: The increasing incidence of diseases associated with aging, such as chronic conditions and cognitive decline, is driving interest in complementary therapies that aim to improve health outcomes and overall well-being in older adults.
Shift Towards Holistic Health Approaches: A growing awareness of holistic health approaches and the desire for natural and non-invasive treatments are encouraging consumers to explore CAM options for anti-aging and longevity.

Future Opportunities and Market Potential

Substantial Market Opportunity: The CAM market for anti-aging and longevity is expected to account for an absolute dollar opportunity of nearly USD 347.7 billion from 2022 to 2032. This presents a significant growth potential for industry players to capitalize on emerging trends and consumer demands.
Innovation in CAM Products and Services: As research continues to support the efficacy of various CAM modalities, there will be opportunities for innovation in product development, including herbal supplements, dietary formulations, and alternative therapies that cater to aging populations.
Increased Accessibility of CAM Treatments: The expansion of online platforms and wellness centers offering CAM services is expected to improve accessibility, further driving market growth and consumer adoption.

The market for complementary and alternative medicine for anti-aging and longevity is poised for extraordinary growth, fueled by demographic shifts, increasing health consciousness, and the demand for effective and natural therapeutic options.

Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision.

Over the past decade, healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancement in technology has created impressive scope within the medical sector for diagnostics and therapeutics.

The report offers extensive data sets validating key trends impacting growth in the Complementary and Alternative Medicine for Anti Aging & Longetivity industry. It offers insights into strategies adopted by the key players rise and address the concerns that will challenge the growth of Complementary and Alternative Medicine for Anti Aging & Longetivity market.

With our extensive research and information about the past, current and future market scenario, the Complementary and Alternative Medicine for Anti Aging & Longetivity industry report will help and identify the concerns, for a smooth-sail of the small & medium as well as large enterprises.

A Full Report Overview

Market Segments Covered in Complementary and Alternative Medicine for Anti-Aging & Longevity Market Analysis

By Intervention Type:

Body Healing
- Yoga
- Acupuncture & Massage
- Chiropractic
- Qigong & Tai chi
- Kinesiology
- Reflexology
- Eurythmy
- Other Body Healings
Traditional Alternative Medicine/Traditional Alternative Medicine/Botanicals
- Ayurveda
- Naturopathic Medicine
- Traditional Chinese Medicine
- Zang Fu Theory
- Other Traditional Alternative Medicine/Traditional Alternative Medicine/Botanicals
Mind Healing
- Meditation & Mindfulness
- Relaxation
- Other Mind Healings
External Energy Healing
- Magnetic & Electromagnetic therapy
- Chakra healing
- Reiki
- Other External Energy Healings
Sensory Healing
- Aromatherapy
- Sound healing

By Customer Type:

High Net Worth (HNW) Individuals
Very High Net Worth (VHNW) Individuals
Ultra-high Net Worth (UHNW) Individuals
Other Customer Types

Comprehensive analysis of the regional markets offers exclusive insights on the market performance across geographies along with relevant graphs, figures, and list of tables.

Competitive Analysis

By Prominent Market Players

The key players in the global Complementary and Alternative Medicine for Anti-Aging & Longevity market are Anadolu Medical Center, Sinomedica, Acupuncture Enfants, and Ayurveda Kuwait.

With an extensive SWOT analysis, the FMI’s study presents the strengths, weaknesses, growth prospects and challenges of each player. The report also includes important data including the sales strategy, pricing strategy, and marketing strategy adopted by these players in the Complementary and Alternative Medicine for Anti Aging & Longetivity industry

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Bone Grafts and Substitutes Market Set for Significant Growth Projected Valuation of Nearly USD 6.3 Billion by 2032 at a 7.1% CAGR

The global bone grafts and substitutes market was estimated to be worth USD 2.9 billion in 2021 and is expected to reach USD 6.3 billion by 2032, according to a recent industry analysis conducted by Future Market Insights (FMI). According to the report’s findings, the spinal fusion deployment mechanism sector, which generates the majority of market revenue, will continue to be significant. According to the deployment model, the spinal fusion market is expected to develop at a compound annual growth rate (CAGR) of 6.9% by 2032. The growing number of spinal cord injury (SCI) cases globally is mostly to blame for the growing demand for bone replacements and grafts in the spinal fusion market.

The US to Command the Larger Proportion of Bone Grafts and Substitutes Market throughout the Analysis Period

The United States controls 37.3% of the market and is expected to maintain its position with an absolute opportunity growth of US$ 1.2 billion to reach a valuation of US$ 2.4 billion by 2032. Its demand in the United States is expected to rise due to the rapidly increasing demand for bone grafts and substitutes in Spinal Cord Injuries (SCIs). According to the CDC, 67 million adults in the United States will have arthritis by 2030, increasing the demand for bone grafts, which are required for arthritis treatment.

“The application of allograft bone grafts in demineralized bone matrices procedures have significant potential to emerge as a key market driver during the forecast period for the Bone Grafts and Substitutes market.”comments an analyst at Future Market Insights.

Bone Grafts and Substitutes Market: Competition Insights

Currently, Bone Grafts and Substitutes providers are largely aiming at adopting strategies such as mergers, acquisitions, and partnerships. They are working towards finding a balance between expanding their product portfolio and capitalizing on the growing market demand. The key companies operating in the Bone Grafts and Substitutes market include Allosource, DePuySynthes Inc., Baxter, NuVasive Inc., Smith & Nephew, Medtronic, Orthofix Holdings Inc., TBF Tissue Engineering, Stryker Corporation, OrthoFix Medical Inc., MedBone Biomaterials, and SeaSpine.

The key recent developments of Bone Grafts and Substitutes manufacturers are as follows:

Orthofix Medical Inc. launched Opus B.A., a highly efficient and synthetic bioactive bone graft solution, in February 2022 to aid in the process of cervical and lumbar spine fusions.
NuVasive Inc. acquired Simplify Medical in February 2021 to strengthen the company’s cervical portfolio, thereby expanding its growth avenues during the forecast period.
Wright Medical Group N.V. will be acquired in November 2020. Stryker Corporation completed the project. The acquisition of this medical equipment company specialising in extremities and biologics is expected to help Stryker Corporation improve its bone graft substitute portfolio and expand its market position.
Baxter’s Altapore Shape bioactive bone graft was approved by the FDA in July 2020. Among the many benefits of this bone graft is improved bone growth.

A Full Report Overview

Key Segments Covered in Market Survey

The Bone Grafts and Substitutes Market is segmented based on material type, deployment mode, and region.

By Material Type:

Allograft
- Demineralized Bone Matrix
- Other Allografts
Synthetic
- Ceramics
- Composites
- Polymers
- Bone Morphogenic Proteins (BMP)

By Deployment Mode:

Craniomaxillofacial
Dental
Foot & Ankle
Joint Reconstruction
Long Bone
Spinal Fusion

By Region:

North America
- The USA
- Canada
Asia Pacific
- China
- Japan
- South Korea
- India
Europe
- Germany
- United Kingdom
- France
- Russia
- Italy
The Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- United Arab Emirates(UAE)
- Nigeria
- Egypt
Latin America
- Mexico
- Brazil
- Argentina
- Colombia

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Intraocular Lens Market Projected Growth to Reach USD 8.2 Billion by 2032 at a 6% CAGR

the Global Intraocular Lens Industry. The comprehensive report outlines a trajectory of success for the sector, predicting sales to reach US$ 4.3 billion in 2021 and projecting an impressive Compound Annual Growth Rate (CAGR) of 6% from 2022 to 2032. This projection is expected to elevate the market’s value to an estimated US$ 8.2 billion by 2032.

One of the standout trends highlighted in the report is the surging demand for Multifocal Intraocular Lenses. Projections indicate that this segment will experience the highest growth, boasting a CAGR of 6.1% over the period from 2022 to 2032.

This comprehensive report not only provides invaluable insights into the current dynamics of the Intraocular Lens market but also offers a glimpse into its future prospects. It stands as an essential resource for both established and emerging market players, equipping them with crucial information to make informed decisions.

COVID-19 Impact Analysis on Intraocular Lens Industry

The recent outbreak of COVID-19 has turned the spotlight on the healthcare industry and subsequently impacted the Intraocular Lens industry. Severe shortages of critical medical supplies and a rapid rise in the number of COVID-19 cases have resulted in a revolution rather than an evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Intraocular Lens market.

Following government measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMI’s report includes an interesting chapter on the preliminary impact of COVID-19 on the Intraocular Lens market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

Intraocular Lens Industry: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Intraocular Lens industry. Competitive information detailed in the Intraocular Lens market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Intraocular Lens market report.

Key players covered in the report include:

Alcon, Inc. (a Novartis AG division), Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, EyeKon Medical, Inc., Lenstec, Inc., Human Optics AG and Physiol

A Full Report Overview

Intraocular Lens Industry: Segmentation

Valuable information covered in FMI’s Intraocular Lens market report has been segregated into key segments and sub-segments.

By Product Type:

Monofocal Intraocular Lens
Multifocal Intraocular Lens
Toric Intraocular Lens
Accommodative Intraocular Lens

By End-User:

Hospitals
Ophthalmic Clinics
Ambulatory Surgery Centers
Eye Research Institutes

About Future Market Insights (FMI)

Contact Us:

Anxiety Disorders and Depression Treatment Market Projected Valuation to Reach Nearly USD 16.1 Billion by 2032 at a 3.4% CAGR

The global Anxiety Disorders and Depression Treatment Market was valued at approximately USD 11.2 billion in 2021. With a projected CAGR of 3.4% over the next decade, the market is anticipated to reach nearly USD 16.1 billion by the end of 2032.

Key Drivers of Market Growth

Several factors are expected to drive the growth of the anxiety disorders and depression treatment market in the coming years:

Collaborative Efforts to Raise Awareness: Joint initiatives by pharmaceutical companies, non-governmental organizations (NGOs), mental health advocacy groups, and government bodies are focusing on raising public awareness about anxiety and depression. These efforts aim to reduce stigma, encourage treatment, and improve overall mental health literacy.
Increasing Prevalence of Mental Health Disorders: The growing recognition of anxiety disorders and depression as significant public health issues is expected to lead to an increase in diagnosis and treatment-seeking behavior among individuals affected by these conditions.
Advancements in Treatment Options: The development of new and more effective therapies, including medications and therapeutic interventions, is likely to expand treatment options for patients, further driving market growth.

Among all mental health problems, major depressive disorder (MDD) is the leading source of chronic health-related burden. The COVID-19 pandemic has compounded the situation by introducing a number of unclear circumstances that have an impact on mental health, such as virus transmission, blockade and ban, public transport limits, school and company closures, and decreased social interaction. As a result, the threat of MDD has grown, as has the health-care burden and demand for antidepressant medicines in Europe.

Reimbursement laws for drugs and therapeutic techniques in developed countries, together with their high levels of effectiveness, are projected to increase demand in the area during the projection period. However, because to the high expense of equipment and therapies such as anaesthesia and hospitalisation, patient preference has shifted towards pharmaceuticals. In terms of distribution channels, the anxiety and depression medications market in Europe is expected to have the greatest CAGR in the future years. Consumers are drawn to internet shopping for its convenience, which includes the option to order from home, enjoy discounts, and receive doorstep delivery.

Key Takeaways

The anxiety disorders and depression treatment market in the UK to be worth US$ 665.5 Million by 2032, generating a dollar opportunity of US$ 141.2 Million
European market for anxiety disorders and depression treatment is presumed to grow at a CAGR of 2.4%.
In Europe, Poland and Romania have the lowest reported incidence of anxiety and depression.
Greece has the highest depression prevalence, preceded by Spain and Portugal.
In the Anxiety Disorders and Depression Treatment Market, the depression segment is taking central place.

Competitive Landscape

Because of technological advancements, a large number of players are based in developing nations. However, because of modern connectivity, these participants have also penetrated emerging economies and are attempting to build an industry in these countries as well.

Market players intend to invest in technological innovations, mergers and acquisitions, new product launches, and study and development. Furthermore, they are likely to place a stronger emphasis on investing in novel developments and items to widen their market reach.

Recent Developments

The European Medicines Agency (EMA) approved H. Lundbeck A/submission S’s for Vyepti for evaluation of the Marketing Authorization Application in December 2020. (MAA). The application requests that Vyepti be made available to European residents who undergo from migraine and are eligible for preventive care therapy. Vyepti’s objective is to avoid calcitonin gene-related peptide (CGRP) from interacting with its receptor, thereby preventing migraine attacks.
Novartis announced in December 2020 that it would acquire Cadent Therapeutics for a total consideration of up to US$ 770 million. Novartis will be able to profit from Cadent’s entire neuroscience portfolio as a result of the acquisition, increasing its market share in the field of mental health.
HMNC Brain Health reported encouraging top-line results from its Phase 2 Proof-of-Concept investigator-initiated trial of its oral prolonged-release composition of ketamine (KET01) in Treatment-Resistant Depression in March 2022. (TRD).

A Full Report Overview

Key Segments Covered in Anxiety Disorders and Depression Treatment Market Survey

Anxiety Disorders and Depression Treatment Market by Drug Class:

Antidepressants
Anxiolytics
Anticonvulsants
Noradrenergic Agents
Atypical Antipsychotics

Anxiety Disorders and Depression Treatment Market by Indication:

Anxiety
Depression

Anxiety Disorders and Depression Treatment Market by Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Healthcare Analytical Testing Services Market Envisions a Robust USD 49.6 billion Valuation by 2032 at a 14% of CAGR

The global healthcare analytical testing services market is expected to be worth US$ 11.9 billion by 2021. The market is anticipated to increase at a 14% compound annual growth rate (CAGR) during the following ten years, to reach a value of US$ 49.6 billion by the end of 2032.

With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Healthcare Analytical Testing Services Market. FMI offers insights into the Market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming Market scenario for the Healthcare Analytical Testing Services Market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision.

The report offers extensive data sets validating key trends impacting growth in the Healthcare Analytical Testing Services Market. It offers insights into strategies adopted by the key players rise and address the concerns that will challenge the growth of Healthcare Analytical Testing Services Market. With our extensive research and information about the past, current and future Market scenario, the Healthcare Analytical Testing Services Market report will help and identify the concerns, for a smooth-sail of the small & medium as well as large enterprises.

Healthcare Analytical Testing Services Market: Segmentation

By Region:
•North America
•Latin America
•Europe
•Asia Pacific
•Middle East & Africa

By Segment:
By Product Type:
•Medical Device
oExtractable & Leachable
oMaterial Characterization
oPhysical
oBioburden
oSterility
oOther Medical Devices
•Pharmaceutical
oBioanalytical
oMethod Development & Validation
oStability
oOther Services

Comprehensive analysis of the regional Markets offers exclusive insights on the Market performance across geographies along with relevant graphs, figures, and list of tables.

Competitive Analysis
By Prominent Market Players
•Eurofins Scientific
•Pace Analytical Services LLC
•Intertek Group
•Toxikon, Inc.
•SGS SA
•Syneos Health
•Charles River Laboratories International Inc.
•Labcorp
•ICON plc
•WUXI Apptec

With an extensive SWOT analysis, the FMI’s study presents the strengths, weaknesses, growth prospects and challenges of each player. The report also includes important data including the sales strategy, pricing strategy, and Marketing strategy adopted by these players in the Healthcare Analytical Testing Services Market

A Full Report Overview

Key Segments:

By Product Type:
•Medical Device
oExtractable & Leachable
oMaterial Characterization
oPhysical
oBioburden
oSterility
oOther Medical Devices
•Pharmaceutical
oBioanalytical
oMethod Development & Validation
oStability
oOther Services

By Region:
•North America
•Latin America
•Europe
•Asia Pacific
•Middle East & Africa

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Non-Alcoholic Steatohepatitis Clinical Trials Market Projected Growth to Reach USD 5.1 Billion by 2032 at a 7% of CAGR

The Global Non-Alcoholic Steatohepatitis Clinical Trials Market size will be worth approximately USD 2.6 billion in 2022. However, the market is expected to grow significantly between 2022 and 2032, with a projected growth rate of 7%, which is higher than the historical increase. Phase 3 is estimated to be the highest revenue-generating sector in the Non-Alcoholic Steatohepatitis Clinical Trials Market, with a CAGR of 11.2% from 2022 to 2032.

Market for Non-Alcoholic Steatohepatitis Clinical Trials from 2017 to 2021 in terms of revenue In contrast to the Demand Forecast for 2022 to 2032

According to Future Market Insights, a market research and competitive intelligence provider, the market value of this disease increased at a compound annual growth rate (CAGR) of about 6.2% between 2017 and 2021, with the United States, the United Kingdom, China, and Japan accounting for a sizable portion of the global market.

Furthermore, technological advancements, an ageing population, an increase in the prevalence of chronic diseases, and an increase in surgical procedures are key drivers of the expansion. As a result, the market for clinical trials for non-alcoholic steatohepatitis is predicted to increase at a CAGR.

How did the market for Non-Alcohol Steatohepatitis Clinical Trials perform during the pandemic?

Trials were suspended due to decreased patient participation in clinical research and supply chain issues induced by the epidemic. In contrast, virtual participants and COVID-compliant screening permitted select organisations to complete the trials. Novartis, for example, conducted a phase two trial of a specific medication for non-alcoholic steatohepatitis after the drug was designated as a breakthrough treatment in the United States. In 2021, semaglutide will be started in patients with non-alcoholic steatohepatitis (NASH) in phase 3a. The results of a phase two proof-of-concept investigation in NASH were reported by Novo Nordisk and Gilead Sciences. In the United States, NASH is the second most common reason for a liver transplant. NASH has also been associated to hepatocellular carcinoma.

The results of a phase two proof-of-concept study in NASH were revealed by Nordisk and Gilead Sciences. The second most common reason for liver transplants in the US is NASH. Several studies have found a connection between NASH and hepatocellular cancer growth.

Analysis by country

The USA Clinical Trials for Non-Alcoholic Steatohepatitis: Market Research

NAFLD is one of the most common chronic liver diseases in the United States. In the United States, approximately 20% of adults are estimated to have NASH, while approximately 25% are thought to have NAFLD. Given these troubling statistics, the Non-Alcoholic Steatohepatitis Clinical Trials market in the United States is expected to grow at a 7.5% CAGR from 2022 to 2032, reaching a value of US$ 1.9 billion.

Because to pathologist bias, it can be difficult to divide patients into discrete fibrosis phases in NASH trials. Sagimet Biosciences is using digital histopathology in its Stage IIb non-alcoholic steatohepatitis (NASH) inquiry to achieve more accurate and consistent biopsy analysis. Histological imaging of biopsy samples is used in digital pathology for NASH, which is then analysed using artificial intelligence (AI) to detect fibrosis abnormalities. TVB-2640 is being studied in the Phase IIb FASCINATE-2 trial (NCT04906421) by Sagimet and HistoIndex, a Singapore-based diagnostic firm.

A Full Report Overview

Market Segments Covered in Non-Alcoholic Steatohepatitis Clinical Trials Market Analysis

By Study Design:

Interventional
Observational
Expanded Access

By Phase:

Phase 1
Phase 2
Phase 3
Phase 4

By Region:

North America
Latin America
Asia-Pacific (APAC)
Middle East and Africa (MEA)
Europe

About Future Market Insights (FMI)

Contact Us:

Medical Fiber Optics Market Analysis Projected Growth to Exceed USD 2 Billion by 2032 at a 6.9% of CAGR

Global sales of medical fibre optics market size are expected to reach USD 988.3 million in 2021, according to the Future Market Insights Medical Fibre Optics Market industry study report. With a 6.9% CAGR from 2022 to 2032, the market is projected to reach a worth of USD 2 billion by 2032. The most lucrative fibre type is anticipated to be multimode optical fibre, which will grow at a 7% CAGR between 2022 and 2032.

The medical fiber optics market is being driven by technological improvements in the electronics and healthcare industries. During the forecast period, the medical fiber optics market is likely to see new growth prospects due to the adoption of improved and innovative technologies relevant to medical surgeries and operations via medical fiber optics technology.

Furthermore, as the prevalence of gastrointestinal illnesses, particularly peptic ulcers, rises, the demand for diagnostic equipment is likely to rise. As a result, demand for medical fiber optics for diagnostic applications is likely to rise.
During the projected period, the medical fiber optics market is likely to benefit from rising health awareness and increased availability of medical facilities around the world. The healthcare industry is expanding at a rapid pace.
Furthermore, the number of hospitals and healthcare facilities is rapidly expanding. During the projected period, these factors are expected to enhance the medical fiber optics market. The medical fiber optics industry, on the other hand, is benefiting from the advancement of fiber optics technologies.

The utility of fiber optics has enabled first responders to take swift action at the scene of a medical emergency or accident. As an example, the DOT Telemedicine Backpack allows paramedics in the U.S. to acquire information and carry out treatments while away from a hospital setting. Fiber Optic Connectivity allows data from the backpack’s tools to be transmitted for analysis in a brief amount of time, allowing immediate diagnosis and treatment.

Competitive Landscape
Product approvals, new product releases, acquisitions, collaborations, and innovations are all important methods used by leading market players to maintain their market position.
Partnerships and expansion have been prominent development in the Medical
Fiber Optics market in recent years. Integra LifeSciences Holdings Corporation; Molex; SCHOTT; Newport Corporation; Coherent, Inc.; and Timbercon, Inc. are some of the prominent providers in Medical Fiber Optics.

Some of the recent developments of key Medical Fiber Optics providers are as follows:
•In November 2019, Schott AG released the SCHOTT SingleEZ Guide is a plug-and-play illumination solution for single-use endoscopes.

•In March 2019, Schott AG launched Autoclavable Solidur LEDs for use in dental and medical technology applications.
More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Medical Fiber Optics market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of by Fiber Type (Single Mode Optical Fiber, Multimode Optical Fiber), By Application across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Market Segments Covered in Medical Fiber Optics Industry Analysis
By Fiber Type:
•Single Mode Optical Fiber
•Multimode Optical Fiber

By Application:
•Endoscopic Imaging
•Laser Signal Delivery
•Biomedical Sensing
•Illumination
•Other Applications

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Global Industrial Power Supply Market Size Anticipated to Exceed USD 21.5 Billion by 2034, Growing at 10.1% CAGR | FMI Study

The industrial power supply market is estimated to be worth USD 8.2 billion in 2024 and is projected to be valued at USD 21.5 billion in 2034. Between 2024 and 2034, the industry is poised to rise at a CAGR of 10.1%. The growing integration of industrial automation and the implementation of Industry 4.0 initiatives are contributing to a heightened demand for dependable and efficient power supplies. This demand stems from the necessity of providing stable and accurate power delivery to automation systems, encompassing PLCs, robotics, and control systems.

The increasing recognition of the importance of energy conservation and sustainability in industrial settings is fostering a preference for energy-efficient power supplies. Businesses are actively seeking power solutions that not only optimize energy consumption but also contribute to reducing overall operational costs. Global economic growth and the expansion of manufacturing and industrial infrastructure contribute to increased demand for power supplies. As industries expand, there is a need for reliable and scalable power solutions to support new facilities and equipment.

Browse Full report Here

Continuous technological progress, marked by enhancements in power electronics, digital control, and the integration of intelligent features, propels the evolution of highly efficient and advanced industrial power supplies. To remain competitive in this dynamic market, companies are dedicating resources to research and development initiatives.

Key Takeaways from the Market Study:

From 2019 to 2023, the industrial power supply market expanded at a CAGR of 13.2%.
Based on the product types, the AC-DC converters segment is expected to rise at a CAGR of 9.8% from 2024 to 2034.
The industrial power supply demand in China is predicted to grow at a CAGR of 9.2% through 2034.
In the United States, the industrial power supply industry is estimated to register a CAGR of 10.4% from 2024 to 2034.
The United Kingdom is projected to expand by a value CAGR of 10.8% between 2024 and 2034.
The industrial power supply market in Japan is anticipated to record a CAGR of 11.5% during 2034.

“The industrial power supply market is experiencing momentum driven by the growth of manufacturing and industrial infrastructure, coupled with a rising demand for energy-efficient solutions in industrial settings.” says Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.).

Competitive Landscape:

The industrial power supply market players are forming strategic partnerships with other industry players, technology providers, or manufacturers to enhance product portfolios or expand market reach and collaborating with key stakeholders in the supply chain to ensure a seamless and reliable power supply ecosystem.

Leading Manufactures in Industrial Power Supply Market:

TDK Lambda
Delta Electronics
XP Power
Siemens
Murata Power Solutions
Advanced Energy
Bel Fuse
Cosel
MEAN WELL

Recent Developments in Industrial Power Supply Industry:

TDK Lambda – a leading global manufacturer of power supplies, TDK Lambda specializes in providing innovative and reliable solutions for various industrial applications.
Delta Electronics – is a multinational company known for its power and thermal management solutions, offering a wide range of industrial power supply products.
XP Power – is a well-established provider of power solutions, delivering high-quality and efficient power supplies for industrial applications, including medical, technology, and industrial sectors.

Industrial Power Supply Market Segmentation Analysis:

By Product Types:

AC-DC Converters
DC-DC Converters

By Output Power:

Very Low Output (Up to 500W)
Low Output (500W-1,000W)
Medium Output (1,000W-10 kW)
High Output (10-75kW)
Very High Output (75-150kW)

By Vertical:

Transportation
Semiconductor
Military & Aerospace
Robotics
Test & Measurement
Battery Charging & Test
Industrial 3D Printing
Laser
Lighting

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa

Browse Related Reports:

The below 30 Hp centrifugal water pump market is anticipated to reach USD 68.95 million in 2032.

The global heat pump market is anticipated to secure a valuation of USD 58.7 billion by 2033.

The global heavy-duty heat pump market is likely to secure USD 4.8 billion in 2033.

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Hospital Consumables Market Projected Valuation to Exceed USD 1.2 Billion by 2032 at a 12.5% of CAGR

the Global Hospital Consumables Industry, revealing a staggering growth trajectory. According to the report, the global Hospital Consumables market is set to achieve sales of $346 billion in 2021, with a projected growth rate of 12.5% from 2022 to 2032, far exceeding historical averages.

The Hospital Consumables market is expected to generate an absolute dollar opportunity of US$ 853.2 billion, driven by a confluence of factors such as the rising incidence of chronic diseases, increasing medical operations, and the expanding older population.

FMI’s report is based on the latest insights and statistics obtained from the most prominent pharmaceutical and healthcare device manufacturers worldwide. The analysis provides a deep dive into the Hospital Consumables market, offering a comprehensive understanding of current trends and future prospects.

Over the past decade, the healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancement in technology has created impressive scope within the medical sector for diagnostics and therapeutics.

The report offers extensive data sets validating key trends impacting growth in the Hospital Consumables market. It offers insights into strategies adopted by the key players rise and address the concerns that will challenge the growth of Hospital Consumables market. With our extensive research and information about the past, current and future market scenario, the Hospital Consumables market report will help and identify the concerns, for a smooth-sail of the small & medium as well as large enterprises.

Hospital Consumables Market: Segmentation
By Region

North America
Latin America
Europe
APAC
MEA

Detailed analysis on the geographical region and country wise insights are offered in the latest Hospital Consumables market report with established market players as well as incumbents in the region.

A Full Report Overview

Market Segments Covered in Hospital Consumables Industry Analysis
By Product Type:

IV Solutions
Disposable Medical Gloves
IV Kits
Medical Gauze & Tapes
Disposable Syringes
Sharps Disposable Containers
Non-woven Disposable Products
Surgical Blades
Medicine Cups
Cannul
Procedure Trays
Other Product Types

Comprehensive analysis of the regional markets offers exclusive insights on the market performance across geographies along with relevant graphs, figures, and list of tables.

Competitive Analysis

By Prominent Market Players

The key vendors in the global Hospital Consumables Market are McKesson Medical-Surgical Inc., Medline Industries, B. Braun Melsungen A.G., Terumo Medical Corporation, and Owens & Minor.

About Future Market Insights (FMI)

Contact Us: